Woo Kyung Ryu Hyungkeun Cha Mi Hwa Park Jung Soo Kim Jeong-Seok Choi Lucia Kim Kyung-Hee Lee Hae-Seong Nam
10.3389/fonc.2022.900966
Front Oncol
2022 Oct 18;12:900966.
alk (anaplastic lymphoma kinase) ros1 crizotinib interstitial lung disease (ild) tyrosine kinase inhibitor (tki)
CC BY
https://pubmed.ncbi.nlm.nih.gov/36330497/
Case Reports
PMC9625112
36330497
Efficacy of crizotinib retreatment after crizotinib-related interstitial lung disease in a patient with ROS1-rearranged advanced lung adenocarcinoma: A case report and potential crizotinib retreatment strategy
2022